University of Minnisota
Minneapolis, Minnesota, 55414, United States
NCT Number: NCT07821697
TRACE is a record-only study evaluating subgaleal EEG (sgEEG) recorded concurrently with standard-of-care stereoelectroencephalography (SEEG) in adults with drug-resistant epilepsy undergoing inpatient epilepsy monitoring. The study will assess the ability of sgEEG to detect seizures and characterize seizure timing, signal quality and stability, and lateralization compared with SEEG.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Early Phase 1
Minneapolis, Minnesota, 55414, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subgaleal EEG recording
Time frame: During concurrent sgEEG and standard-of-care SEEG monitoring, up to 14 days
The proportion of clinically adjudicated SEEG seizures for which a corresponding event is identified on simultaneously recorded subgaleal EEG (sgEEG). SEEG serves as the reference standard.
Contact information is provided by the study sponsor or research team.
Adraxe Corp.
Industry
Acronym: TRCE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07704606
Brain Diseases, Central Nervous System Diseases
View Trial DetailsNCT07316972
Brain Diseases, Central Nervous System Diseases
View Trial DetailsNCT07249190
Brain Diseases, Central Nervous System Diseases
View Trial DetailsNCT06593444
Brain Diseases, Central Nervous System Diseases
View Trial Details